BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nakahara T, Morimoto H, Murakami N, Furue M. Mechanistic insights into topical tacrolimus for the treatment of atopic dermatitis. Pediatr Allergy Immunol 2018;29:233-8. [PMID: 29205511 DOI: 10.1111/pai.12842] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Paulucci BP. PMMA Safety for Facial Filling: Review of Rates of Granuloma Occurrence and Treatment Methods. Aesth Plast Surg 2020;44:148-59. [DOI: 10.1007/s00266-019-01522-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Meyer NH, Kotnik N, Meyer V, Gibbs BF, Raap U. The Complexity of Pruritus Requires a Variety of Treatment Strategies. Curr Treat Options Allergy 2019;6:189-99. [DOI: 10.1007/s40521-019-00217-y] [Reference Citation Analysis]
3 Furue M, Ulzii D, Vu YH, Tsuji G, Kido-nakahara M, Nakahara T. Atopic Dermatitis and Type 2 Immune Deviation. Curr Treat Options Allergy 2019;6:200-10. [DOI: 10.1007/s40521-019-00219-w] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kandikattu HK, Mishra A. Immunomodulatory effects of tacrolimus (FK506) for the treatment of allergic diseases. Int J Cell Biol Physiol 2018;1:5-13. [PMID: 31595270 DOI: 10.5281/zenodo.2530969] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Petrova E, Hovnanian A. Advances in understanding of Netherton syndrome and therapeutic implications. Expert Opinion on Orphan Drugs 2020;8:455-87. [DOI: 10.1080/21678707.2020.1857724] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wu X, Liu J, Chen C, Huang Z, Zang Y, Chen J, Dong L, Zhang J, Ding Z. 3,3'-Diindolylmethane alleviates acute atopic dermatitis by regulating T cell differentiation in a mouse model. Mol Immunol 2021;130:104-12. [PMID: 33309306 DOI: 10.1016/j.molimm.2020.11.013] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Kandikattu HK, Venkateshaiah SU, Verma AK, Mishra A. Tacrolimus (FK506) treatment protects allergen-, IL-5- and IL-13-induced mucosal eosinophilia. Immunology 2021;163:220-35. [PMID: 33512727 DOI: 10.1111/imm.13314] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Takemura M, Nakahara T, Hashimoto-Hachiya A, Furue M, Tsuji G. Glyteer, Soybean Tar, Impairs IL-4/Stat6 Signaling in Murine Bone Marrow-Derived Dendritic Cells: The Basis of Its Therapeutic Effect on Atopic Dermatitis. Int J Mol Sci 2018;19:E1169. [PMID: 29649105 DOI: 10.3390/ijms19041169] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
9 Yang N, Chen Z, Zhang X, Shi Y. Novel Targeted Biological Agents for the Treatment of Atopic Dermatitis. BioDrugs 2021;35:401-15. [PMID: 34213742 DOI: 10.1007/s40259-021-00490-x] [Reference Citation Analysis]
10 Furue M. Regulation of Skin Barrier Function via Competition between AHR Axis versus IL-13/IL-4‒JAK‒STAT6/STAT3 Axis: Pathogenic and Therapeutic Implications in Atopic Dermatitis. J Clin Med 2020;9:E3741. [PMID: 33233866 DOI: 10.3390/jcm9113741] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
11 Li M, Tan W, Du J, Wang Q, Wang L, Lei M, Hao PS. Tacrolimus ointment in the treatment of hormone-dependent dermatitis: A protocol of systematic review. Medicine (Baltimore) 2020;99:e22159. [PMID: 32925777 DOI: 10.1097/MD.0000000000022159] [Reference Citation Analysis]
12 Zhang QQ, Xu P, Sun C, Liu LJ, Jiang WW. Topical tacrolimus with different frequency for exfoliative cheilitis: a pilot study. J Dermatolog Treat 2020;:1-5. [PMID: 32431191 DOI: 10.1080/09546634.2020.1771258] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Weidinger S, Beck LA, Bieber T, Kabashima K, Irvine AD. Atopic dermatitis. Nat Rev Dis Primers 2018;4. [DOI: 10.1038/s41572-018-0001-z] [Cited by in Crossref: 349] [Cited by in F6Publishing: 306] [Article Influence: 87.3] [Reference Citation Analysis]
14 Miyano K, Tsunemi Y. Current treatments for atopic dermatitis in Japan. J Dermatol 2021;48:140-51. [PMID: 33377547 DOI: 10.1111/1346-8138.15730] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kasai H, Kawasaki H, Fukushima-Nomura A, Yasuda-Sekiguchi F, Amagai M, Ebihara T, Tanese K. Stratification of atopic dermatitis patients by patterns of response to proactive therapy with topical tacrolimus: low serum IgE levels and inadequately controlled disease activity at the start of treatment predict its failure. Ann Med 2021;53:2205-14. [PMID: 34797182 DOI: 10.1080/07853890.2021.2004319] [Reference Citation Analysis]
16 Sawangjit R, Dilokthornsakul P, Lloyd-lavery A, Chua S, Lai NM, Dellavalle R, Chaiyakunapruk N; Cochrane Skin Group. Systemic treatments for eczema: a network meta-analysis. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd013206] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
17 Melo A, Carrascosa JM, Torres T. Baricitinib for the treatment of atopic dermatitis. J Dermatolog Treat 2021;:1-10. [PMID: 34379541 DOI: 10.1080/09546634.2021.1967268] [Reference Citation Analysis]
18 Wong LS, Yen YT, Lee CH. The Implications of Pruritogens in the Pathogenesis of Atopic Dermatitis. Int J Mol Sci 2021;22:7227. [PMID: 34281281 DOI: 10.3390/ijms22137227] [Reference Citation Analysis]
19 Eigenmann P. Editorial comments on this issue of the Journal. Pediatr Allergy Immunol 2018;29:231-2. [PMID: 29532579 DOI: 10.1111/pai.12891] [Reference Citation Analysis]